术前中性粒细胞与淋巴细胞比与卵巢癌关系的研究进展  

作　　者：唐英[1,2] 徐凡[1] 胡辉权[1] 周密[1] 李均[1] 舒显竹[2] 

机构地区：[1]川北医学院附属南充市中心医院,四川南充637000 [2]川北医学院

出　　处：《妇产与遗传（电子版）》2016年第2期45-48,共4页Obstetrics-Gynecology and Genetics (Electronic Edition)

基　　金：四川省科技厅基金项目(No:2015JY0056);南充市科技局基金项目(No:14A0098)

摘　　要：卵巢癌是妇科恶性肿瘤中死亡率较高的肿瘤之一,大多数卵巢癌诊断时已经是中晚期,诊治均比较困难。中性粒细胞与淋巴细胞比(neutrophil to lymphocyte ratio,NLR)是近年研究较多的炎症指标,有研究提示术前高水平的NLR与卵巢癌患者的诊断、病情进展、满意肿瘤细胞减灭术等密切相关,是影响卵巢癌患者预后的独立危险因素。本文就NLR与卵巢癌的关系予以综述。Ovarian cancer is one the of leading higher mortality rate of gynecological malignancies, and most patients are in the late stage when disgnosed, which bring difficulty in diagnosis and treatment. In recent years, inflammatory marker neutrophil to lymphocyte ratio （NLR） becomes an research hotspot. Preliminary studies have found that NLR level, which was closely associated with ovarian cancer, such as diagnosis, disease progression, tumor satisfaction cytoreductive surgery and so on, was an independant factors for prognosis for ovarian cancer patients. In this paper, the relationship between ovarian cancer and NLR will be reviewed.

关 键 词：卵巢肿瘤 中性粒细胞与淋巴细胞比 预测价值 

分 类 号：R737.31[医药卫生—肿瘤]